Harry W. Herr - Concepedia

Author

Harry W. Herr

Also Known As

H Herr, H W Herr, HARRY HERR, HARRY W. HERR, Harry HERR, Harry Herr, Harry Herr*, Harry Herr, M.D., Harry W Herr, Harry W Herr MD

718

Publications

41.4K

Citations

104

H-Index

141

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University

About

Harry W. Herr is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	59	157	12K
2	Health Sciences	11	11	554
3	Public Health	8	8	407
4	Diagnostic Sciences	6	6	151
5	Anatomy	2	2	40

Harry W. Herr

351

Publications

34.8K

Citations

100

H-Index

Page 1

	Year	Citations
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology Ahmad Shabsigh, Ruslan Korets, Kinjal Vora, European Urology Standardized Reporting MethodologyRadical CystectomyUrologySurgical OncologyUrological Research	2008	1.4K
Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales, The Journal of Urology	1992	783
Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar, Journal of Clinical Oncology	1999	726
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse Cora N. Sternberg, Alan Yagoda, Howard I. Scher, Cancer	1989	673
Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium Cora N. Sternberg, Alan Yagoda, Howard I. Scher, The Journal of Urology	1985	659
M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium Cora N. Sternberg, Alan Yagoda, Howard I. Scher, The Journal of Urology	1988	627
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Journal of the National Comprehensive Cancer Network	2020	619
Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report Harry W. Herr, James R. Faulkner, H. Barton Grossman, Journal of Clinical Oncology	2004	597
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial Bernard H. Bochner, Guido Dalbagni, Daniel D. Sjoberg, European Urology LaparoscopyUrologySurgical OncologyRandomized Clinical TrialOpen Procedure	2014	586
IMPACT OF THE NUMBER OF LYMPH NODES RETRIEVED ON OUTCOME IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER Harry W. Herr, Bernard H. Bochner, Guido Dalbagni, The Journal of Urology	2002	583

Page 1